Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers-Reference-Cited by-同舟云学术

Enhanced expression of PD L1 in cervical intraepithelial neoplasia and cervical cancers

Published:2015-09-25 Issue:12 Volume:28 Page:1594-1602
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Mezache Louisa,Paniccia Bernard,Nyinawabera Angelique,Nuovo Gerard J

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2015108.pdf

Reference24 articles.

1. zur Hausen H . Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690–698.

2. Bosch FX, Lorincz A, Munoz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244–265.

3. Stoler MH . The virology of cervical neoplasia: an HPV-associated malignancy. Cancer J 2003;9:360–367.

4. Nuovo GJ . The role of HPV in gynecologic diseases: an update. Critical Reviews in Clin Lab Sciences 2000;37:183–215.

5. Nuovo GJ. Low grade Squamous Intraepithelial Lesions. In: Nuovo GJ Cytopathology of the female genital tract: An integrated approach. Williams and Wilkins: Baltimore, 1993, pp 155–214.

Cited by 239 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Advances in the Study of CMTM6, a Focus on Its Novel Non-Canonical Cellular Locations, and Functions beyond Its Role as a PD-L1 Stabilizer;Cancers;2024-09-11

2. SEOM-GEICO Clinical Guidelines on cervical cancer (2023);Clinical and Translational Oncology;2024-08-31

3. Pharmacotherapy for cervical cancer: current standard of care and new perspectives;Expert Opinion on Pharmacotherapy;2024-08-12

4. Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy;Frontiers in Oncology;2024-08-05

5. First-Line Treatment With Atezolizumab Plus Bevacizumab and Chemotherapy for US Patients With Metastatic, Persistent, or Recurrent Cervical Cancer: A Cost-Effectiveness Analysis;Value in Health;2024-08